CVS Health Corp (CVS)

Momentum in medical and tech-focused small caps continues to explode, led by

Synergy CHC Corp. (NASDAQ: SNYR) is capturing national attention with the announcement of a strategic distribution partnership with McKesson Canada, a division of McKesson Corporation (NYSE: MCK) . The agreement gives FOCUSfactor® direct access to thousands of pharmacies and health-focused retailers across Canada, igniting the next phase of its aggressive North American expansion.

Backed by $1 million in funding from the CVS Health Foundation, the pilot initiative offers free, virtual health screenings to support aging with confidence, care, and convenience   Health checks include assessments for heart health, memory, cognitive function, and mental health No travel required — all appointments are virtual and confidential Community Health Workers provide […]

EQNX::TICKER_START (OTCQB:TREIF),(CSE:TRUE),(NYSE:CVS),(NYSE:TDOC),(NASDAQ:TEM),(NYSE:HIMS) EQNX::TICKER_END

Backed by $1 million in funding from the CVS Health Foundation, the pilot initiative offers free, virtual health screenings to support aging with confidence, care, and convenience

PALM BEACH, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The global telehealth market has been substantially growing over the past years and is expected to continue this growth well into the future. A report from Grand View Research said that: “The global telehealth market size was estimated at USD 123.26 billion in 2024 and is projected to reach USD 455.27 billion by 2030, growing at a CAGR of 24.68% from 2025 to 2030. North America dominated the telehealth market with the revenue share of 46.58% in 2024. The market is primarily driven by the increasing adoption of digital health & smartphones, rising investments, improved internet connectivity, and growing technological advancements… the growing adoption and acceptance of telehealth services are expected to boost the market's growth over the forecast period.” The report continued: “Moreover, smartphones have evolved from devices of communication & entertainment to devices that can monitor health and fitness. Some market players are developing Chatbot services for basic medical inquiries and one-time consultations… Moreover, the market is propelled by favorable government initiatives to expand telehealth by making healthcare services more accessible and convenient for patients. The focus on cost-effective and efficient healthcare solutions further propels the adoption of telehealth services. The rising adoption of telehealth facilities by patients, physicians, and government authorities is boosting the market. Access to healthcare through specific applications and video consultations enables communication between patients and doctors in remote locations, eliminating the need to visit hospitals or clinics. Market players such as Apple, Google, and IBM focus on improving the mobile health experience by providing numerous solutions through different subscription plans and emphasizing data security. These factors are expected to drive the market growth over the forecast period.”   Active tech companies in the markets this week include Treatment AI, Inc. (OTCQB: TREIF) (CSE: TRUE), CVS Health® (NYSE: CVS), Teladoc Health, Inc. (NYSE: TDOC), Tempus AI, Inc. (NASDAQ: TEM), Hims & Hers Health, Inc. (NYSE: HIMS).

Synergy CHC Corp. (NASDAQ: SNYR) has surged over 74% in the last 30 days, fueled by the execution of a sweeping retail expansion strategy for its flagship FOCUSfactor® brand, now available in both supplement and functional beverage form. The brand’s rollout to over 50,000 locations —via Core-Mark, Walmart Canada, Metro Ontario, and Downey Wholesale—marks a major milestone, unlocking national reach across mass retail, grocery, convenience, and independent channels.

Synergy CHC Corp. (NASDAQ: SNYR), a rising consumer staple health company, has announced a wave of major expansion throughout North American for its FOCUSfactor® supplements and functional beverage brands, across mass, grocery, convenience, and wholesale channels. Functional Beverage Momentum

Synergy CHC Corp. (NASDAQ: SNYR), a fast-rising force in the consumer health and wellness space, has appointed Damian Marano as Vice President of Beverage in a strategic move aimed at catapulting the company’s FOCUSfactor Energy Drink into global markets. Marano, a seasoned executive with a decorated history at The Coca-Cola Company (NYSE: KO), brings a wealth of expertise that could unlock powerful international distribution opportunities for the brand.

Synergy CHC Corp. (NASDAQ: SNYR), a provider of consumer health and lifestyle products, most notably “Focusfactor” , today announced a transformative $20 million financing agreement with ACP Agency, LLC , aimed at reducing legacy debt, boosting liquidity, and accelerating the company’s global growth strategy.

Synergy CHC Corp. (NASDAQ: SNYR) is a consumer healthcare and beauty company established in 2010, focuses on marketing and distributing a diverse portfolio of health, wellness, and lifestyle brands across the United States, Canada, and the United Kingdom. The company is anchored by a portfolio of dynamic consumer health and lifestyle brands designed for today's wellness-conscious market:

Synergy CHC Corp. (NASDAQ: SNYR), a leading provider of consumer health and lifestyle products, today announced the appointment of Erik Shields as Vice President of Beverage, effective May 26, 2025. The strategic hire comes as the company accelerates its entry into the fast-growing functional beverage market with the expansion of its flagship brain health brand, FOCUSfactor .

Synergy CHC Corp. (NASDAQ: SNYR) is a consumer healthcare and beauty company established in 2010, focuses on marketing and distributing a diverse portfolio of health, wellness, and lifestyle brands across the United States, Canada, and the United Kingdom. The company is anchored by a portfolio of dynamic consumer health and lifestyle brands designed for today’s wellness-conscious market:

AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a” (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other members of Aetna Health & Life Group, which are operating entities of Aetna Inc. (Aetna) and wholly owned subsidiaries of CVS Health Corporation (CVS Health) [NYSE: CVS]. (Please see below for a detailed listing of the companies.)

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS).

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS).

NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CVS Health Corporation (NYSE: CVS) on behalf of long-term stockholders following a class action complaint that was filed against CVS on July 12, 2024 with a Class Period from May 3, 2023 to April 30, 2024. Our investigation concerns whether the board of directors of CVS have breached their fiduciary duties to the company.

Walgreens Boots Alliance (WBA) is down 60% from its 52-week high, but improving earnings, cost cuts, and a 9.27% dividend yield signal potential recovery.

CVS Health Co. (NYSE: CVS) transformed from one of the largest drug store pharmacy chains in the country to an integrated healthcare company

It can be confusing, but Maplebear Inc. (NASDAQ: CART) is better known as Instacart, the world's largest online grocery marketplace.

NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CVS Health Corporation (NYSE: CVS) on behalf of long-term stockholders following a class action complaint that was filed against CVS on July 12, 2024 with a Class Period from May 3, 2023 to April 30, 2024. Our investigation concerns whether the board of directors of CVS have breached their fiduciary duties to the company.

Surgery Partners is the third-largest operator of ambulatory surgery centers (ASCs) in the United States, with over 200 locations.

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CVS Health Corporation (NYSE: CVS) on behalf of long-term stockholders following a class action complaint that was filed against CVS on July 12, 2024 with a Class Period from May 3, 2023 to April 30, 2024. Our investigation concerns whether the board of directors of CVS have breached their fiduciary duties to the company.

Three forgotten-about, sluggishly performing defensive stocks that could offer value and income potential over the long term.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corporation (“CVS” or “the Company”) (NYSE: CVS) for violations of the securities laws.